EMA considering Novartis biosimilar of Pfizer's Enbrel; Which 5 pharma companies are 'happiest' places to work?;

@FiercePharma: Japan's Kaketsuken at center of major vaccine, blood product records fraud. FiercePharmaAsia story | Follow @FiercePharma

@CarlyHFierce: J&J, AbbVie's Imbruvica builds on case for first-line CLL use at ASH. More | Follow @CarlyHFierce

> India's Cipla has reorganized its top ranks again. Story

> Novartis' ($NVS) Sandoz unit has had its application for a biosimilar of Pfizer's ($PFE) blockbuster Enbrel accepted by the European Medicines Agency after earlier submitting it to the FDA. Release

> Amgen ($AMGN), Novartis, Johnson & Johnson ($JNJ), Merck & Co. ($MRK) and Pfizer have all placed in the top 50 happiest places to work in the U.S., ranked by CareerBliss. Report

Medical Device News

@FierceMedDev: ICYMI yesterday: AstraZeneca, NCI tap French company to develop companion mobile app for cancer drugs. Article | Follow @FierceMedDev

@EmilyWFierce: Google Life Sciences will now be known as "Verily." More | Follow @EmilyWFierce

> FDA gives nod for mini-sponge, gunshot wound dressing device for civilians. Story

> Upstart wins CE mark for first swallowable weight-loss gastric balloon. Article

Biotech News

@FierceBiotech: Busy Roche inks another immuno-oncology discovery pact, this time with Pieris. News | Follow @FierceBiotech

@JohnCFierce: In the category of 'can't make this stuff up,' $NWBO issued a followup statement saying why Leary wouldn't work. More | Follow @JohnCFierce

> Pfizer bets up to $1B on BioAtla's approach to immuno-oncology. More

> Alexion grabs an FDA OK--the 41st of '15--for rare-disease drug Kanuma. News

> Sitting on $25B, Gilead goes shopping for high-dollar buyouts. Article

Drug Delivery News

> 'Smart' hydrogel wound dressing delivers drugs from reservoirs. News

> FDA funds computer simulations in bid to speed up development of long-acting generics. Story

> Clearside closes $20M round for candidates that are injected into the eye's suprachoroidal space. More

> University of Warwick spinout develops first transdermal ibuprofen pain patch. Report

> Metal 'nano-terminator' liquefies on demand to bring cancer down. Article

Pharma Manufacturing News

> FDA gives Sun Pharma go-ahead to manufacture generic version of cancer drug Gleevec. Item

> Associated Press: Taxpayers' tally to entice Novo Nordisk to NC may top $130M. More

> South African health activists protest Sanofi over lack of BCG vaccine. Article

> Catalent production issues at French plant cause delay in GSK launch. Story

> AstraZeneca shuttering Bengaluru, India API plant, citing low demand. Report

Pharma Asia News

> China economy not the main culprit in pharma slowdown, FT says. Article

> Outlook for early 2016 in Asia sees headwinds for Japan, India and Thailand. Report

> Japan's Kaketsuken at center of major vaccine, blood product records fraud. More

> China superbug has already gone global, Danish researcher says. Story

> India a potential center for orphan drug development and demand. Article

Suggested Articles

Pfizer has scored FDA approval for its Humira biosimilar, but it can't launch the product for several years under a patent settlement.

The 3-2 vote on the deal was split along the party lines, spelling trouble for future biopharma M&A deals should Democrats move into the White House.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.